Search Ontology:
ChEBI

beta-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-beta-D-Glcp

Term ID
CHEBI:154644
Synonyms
  • 2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->6)-beta-D-galacto-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranose
  • beta-D-GlcNAc-(1->6)-beta-D-Gal-(1->4)-beta-D-Glc
  • GlcNAc(b1-6)Gal(b1-4)b-Glc
  • GlcNAcbeta1-6Galbeta1-4Glcbeta
  • N-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]oxan-3-yl]acetamide
  • O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->6)-O-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranose
Definition
A linear amino trisaccharide consisting of β-D-glucose at the reducing end having an N-acetyl-β-D-glucosaminyl-(1→6)-β-D-galactosyl group attached at the 4-position.
References
  • glygen:G83540EL
  • glytoucan:G83540EL
  • pubmed:32568414
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-beta-D-Glcp
Phenotype where environments contain beta-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-beta-D-Glcp
Phenotype modified by environments containing beta-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-beta-D-Glcp
Phenotype affecting beta-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-beta-D-Glcp
Human Disease Model